Abstract
In the lung, primary lymphoproliferative disease represents a wide and overlapping spectrum of conditions from reactive polymorphous and polyclonal processes through to various entities of malignant lymphoma (Table 39.1) [1, 2]. The natural history of many of the conditions is variable with further heterogeneity recognized within distinct disease entities. Primary pulmonary lymphoproliferative diseases are rare, whereas secondary pulmonary lymphoma occurs in up to 20.5% of autopsy cases. The lung is a potential organ for tumor deposition in disseminated haemato-lymphoid disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Poletti V, Colella S, Piciucchi S, et al. Haematological disorders and bone marrow transplant recipients. In: Wuyts WA, Cottin V, Spagnolo P, Wells AU, editors. Pulmonary manifesations of systemic diseases. (ERS monograph); 2019. p. 333–58.
Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017.
Fishback N, Koss M. Update on lymphoid interstitial pneumonitis. Curr Opin Pulm Med. 1996;2:429–533.
Escalon JG, Richards JC, Koelsch T, Downey GP, Lynch DA. Isolated cystic lung disease: an algorithmic approach to distinguishing Birt-Hogg-Dubè syndrome, lymphangioleiomyomatosis and lymphocytic interstitial pneumonia. AJR. 2019;212:1260–4.
Shimakage M, Sakamoto H, Harada S, et al. Expression of the Epstein-Barr virus in lymphoproliferative diseases of the lung. Oncol Rep. 2007;17:1347–52.
Bhoopat L, Rangkakulnuwat S, Ya-In C, et al. Relationship of cell bearing EBER and p24 antigens in biopsy-proven lymphocytic interstitial pneumonia in HIV-1 subtype E infected children. Appl Immunohistochem Mol Morphol. 2011;19:547–51.
Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol. 1985;16:700–6.
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9:822–30.
Wu D, Lim MS, Jaffe ES. Pathology of Castleman disease. Hematol Oncol Clin N Am. 2018;32:37–52.
Igawa T, Sato Y. TAFRO syndrome. Hematol Oncol Clin North Am. 2018;32:107–18.
Oksenhendler E. Maladies de Castleman. In: Guillevin L, Meyer O, Hachulla E, et al., editors. Traité de Maladies et syndromes systematiques. 6th ed. Paris: Lavoisier Medicine Sciences; 2015. p. 1064–76.
Terasaki Y, Ikushima S, Matsui S, et al. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman’s disease. Histopathology. 2017;70:1114–24.
Borie R, Cadranel J, Guihot A, et al. Pulmonary manifestations of human herpesvirus-8 during HIV infection. Eur Respir J. 2013;42:1105–18.
Fajgenbaum DC. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Blood. 2018;132:2323–30.
Van Rhee F, Voorhees P, Dispenzieri A, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132:2115–24.
Ahmed S, Kussick SJ, Siddiqui AK, et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer. 2004;40:1320–6.
Adam P, Czapiewski P, Colak S, et al. Prevalence of Achromobacter xyloxidans in pulmonary mucosa associated lymphoid tissue lymphoma in different regions of Europe. Br J Haematol. 2014;164:804–10.
Cordier J, Chailleux E, Lauque D, et al. Primary pulmonary lymphomas. A clinical study of 70 cases in non immunocompromised patients. Chest. 1993;103:201–8.
Borie R, Wislez M, Thabut G, et al. Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. Eur Respir J. 2009;34:1408–16.
Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer. 2004;4:644–453.
Zucca E, Bertoni F. The spectrum of MALT lymphoma at different sites. Biological and therapeutic relevance. Blood. 2016;127:2082–92.
Habermann TM, Ryu JH, Inwards DJ, et al. Primary pulmonary lymphoma. Semin Oncol. 1999;26:307–15.
Borie R, Wislez M, Antoine M, Cadranel J. Lymphoproliferative disorders of the lung. Respiration. 2017;94:157–75.
King LJ, Padley SP, Wotherspoon AC, Nicholson AG. Pulmonary MALT lymphoma: imaging findings in 24 cases. Eur Radiol. 2000;10:1932–8.
Kurtin PJ, Myers JL, Adlakha H, et al. Pathologic and clinical fea- tures of primary pulmonary extranodal marginal zone B-cell lym- phoma of MALT type. Am J Surg Pathol. 2001;25:997–1008.
Nicholson AG, Wotherspoon AC, Diss TC, et al. Pulmonary B-cell non-Hodgkin’s lymphomas. The value of immunohistochemistry and gene analysis in diagnosis. Histopathology. 1995;26:395–403.
Shaikh G, Sehgal R, Mehrishi A, Karnik A. Primary pulmonary plasmacytoma. J Clin Oncol. 2008;26:3089–91.
Shah BK, Shrestha A. Pulmonary plasmacytoma. J Thorac Oncol. 2012;7:923.
Horiuchi T, Hirokawa M, Oyama Y, Kitabayashi A, Satoh K, Shindoh T, et al. Diffuse pulmonary infiltrates as a roentgeno—graphic manifestation of primary pulmonary plasmacytoma. Am J Med. 1998;105:72–4.
Cheah CY, Lingaratnam S, Seymour JF. Rituximab for the treatment of follicular lymphoma. Future Oncol. 2013;9:1283–98.
Morice WG, Colby TV. Lymphoproliferative lung diseases. In: Tomashefski Jr JF, editor. Dail and Hammar’s pulmonary pathology. 3rd ed. Berlin: Springer; 2015. p. 1–46.
Chilosi M, Zinzani PL, Poletti V. Lymphoproliferative lung disorders. Semin Respir Crit Care Med. 2005;26:490–501.
Li G, Hansmann ML, Zwingers T, Lennert K. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology. 1990;16:519–31.
Poletti V, Gurioli C, Piciucchi S, Rossi A, Ravaglia C, Dubini A, Asioli CGL. Intravascular large B cell lymphoma presenting in the lung:the diagnostic value of transbronchial cryobiopsy. Sarcoidosis Vasc Diffuse Lung Dis. 2015;31:354–8.
Lee JS, Tuder R, Lynch DA. Lymphomatoid granulomatosis: radiologic, features and pathologic correlations. Am J Roentgenol. 2000;175:1335–133.
Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ. Diffuse large B-cell lymphoma variants:an update. Pathology. 2020;52:53–67.
Travis WD, Brambilla E, Műller-Hermelink HK, Harris CC. WHO: pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.
Bolaman Z, Kadikoylu G, Polatli M, Barutca S, Culhaci N, Senturk T. Migratory nodules in the lung: lymphomatoi granulomatosis. Leuk Lymphoma. 2003;44:197–200.
Siegloch K, Schmitz N, Wu HS, et al. Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation report. Biol Blood Marrow Transplant. 2013;19:1522–5.
Aoki T, Harada Y, Matsubara E, et al. Long-term remission after multiple relapses in an elderly patient with lymphomatoid granulomatosis after rituximab and high-dose cytarabine chemotherapy without stem-cell transplantation. J Clin Oncol. 2013;31:e390.
Shet T, Suryawanshi P, Epari S, et al. Extranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India. Leuk Lymphoma. 2014;55:2748–53.
Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the international peripheral T-cell lymphoma project. Blood. 2009;113:3931–7.
Tse E, Kwong YL. NK/T cell lymphomas. Best Pract Res Clin Haematol. 2019;32:253–61.
Sverzellati N, Poletti V, Chilosi M, Casoni GL, Hansell DM, Zompatori M. The crazy-paving pattern in granulomatous mycosis fungoides: HRTC-pathologic correlation. J Comput Assist Tomogr. 2006;30:843–5.
Yousen SA, Weiss LM, Colby TV. Primary pulmonary Hodgkin’s disease. Cancer. 1986;57:1217–724.
Radin AI. Primary pulmonary Hodgkin’s disease. Cancer. 1990;65:550–63.
Cartier Y, Johkoh T, Honda O, Müller NL. Primary pulmonary Hodgkin’s disease: CT findings in three patients. Clin Radiol. 1999;54:182–4.
Romero S, Montoro J, Guinot M, et al. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation. Leuk Lymphoma. 2019;60:142–50.
Yoon GY, Kim MY, Shim TS. Posttransplant lymphoproliferative disorder of the thorax: CT and FDG-PET features in a single tertiary referral center. Medicine (Baltimore). 2015;94:e1274.
Poletti V, Chilosi M, Olivieri D. Diagnostic invasive procedures in diffuse infiltrative lung diseases. Respiration. 2004;71:107–19.
Poletti V, editor. Transbronchial cryobiopsy in diffuse parenchymal lung diseases. Berlin: Springer; 2019.
Iqbal S, Depew ZS, Kurtin PJ, et al. Endobronchial ultrasound and lymphoproliferative disorders: a retrospective study. Ann Thorac Surg. 2012;94:1830–4.
Poletti V, Romagna M, Gasponi A, Baruzzi G, Allen KA. Bronchoalveolar lavage in the diagnosis of low-grade, MALT type, B-cell lymphoma in the lung. Monaldi Arch Chest Dis. 1995;50:191–4.
Zoie S, Couderc LJ, Cadranel J, Antoine MA, Epardeau B, Fleury-Feith J, Popa N, Santoli F, Farcet JP, Delfau-Larue MH. Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood. 2004;103:3208–15.
Oh SY, Kim WS, Kim JS, et al. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specifi c relationships and the prognostic factors. Consortiumfor improving survival of lymphoma study. Int J Hematol. 2010;92:510–7.
de Boer JP, Hiddink RF, Raderer M, et al. Dissemination patterns in non-gastric MALT lymphoma. Haematologica. 2008;93:201–16.
Lenz G, Pasqualucci L, editors. Malignant lymphomas: biology and molecular pathogenesis. Berlin: De Gruyter; 2016.
Zinzani PL, Casadei B, Derenzini E, et al. Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens. Hematol Oncol. 2013;31:183–8.
Zinzani PL, Tura S, Cavo M, Lewis RE. Hematology:pathophysiology, diagnosis and treatment. Bologna: Esculapio; 2018.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Poletti, V. et al. (2023). Lymphoproliferative Lung Disorders. In: Cottin, V., Richeldi, L., Brown, K., McCormack, F.X. (eds) Orphan Lung Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-12950-6_39
Download citation
DOI: https://doi.org/10.1007/978-3-031-12950-6_39
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-12949-0
Online ISBN: 978-3-031-12950-6
eBook Packages: MedicineMedicine (R0)